Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Non-Current Liabilities: 2019-2025

Historic Total Non-Current Liabilities for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $149.7 million.

  • Harmony Biosciences Holdings' Total Non-Current Liabilities fell 11.97% to $149.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.7 million, marking a year-over-year decrease of 11.97%. This contributed to the annual value of $165.0 million for FY2024, which is 8.70% down from last year.
  • Harmony Biosciences Holdings' Total Non-Current Liabilities amounted to $149.7 million in Q3 2025, which was down 3.30% from $154.8 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Total Non-Current Liabilities peaked at $196.5 million during Q2 2021, and registered a low of $149.7 million during Q3 2025.
  • For the 3-year period, Harmony Biosciences Holdings' Total Non-Current Liabilities averaged around $171.2 million, with its median value being $173.2 million (2024).
  • Per our database at Business Quant, Harmony Biosciences Holdings' Total Non-Current Liabilities increased by 0.40% in 2022 and then declined by 11.97% in 2025.
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Total Non-Current Liabilities stood at $193.2 million in 2021, then fell by 0.52% to $192.1 million in 2022, then declined by 5.97% to $180.7 million in 2023, then fell by 8.70% to $165.0 million in 2024, then decreased by 11.97% to $149.7 million in 2025.
  • Its Total Non-Current Liabilities was $149.7 million in Q3 2025, compared to $154.8 million in Q2 2025 and $159.9 million in Q1 2025.